Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

The year Leah Mayfield died, Bayer HealthCare made $600 million on its popular birth control pill, Yaz. The drug, also known by the brand name Yasmin and the generic brand Ocella, was touted for the added benefit of stomping out the bothersome symptoms of severe premenstrual syndrome, or premenstrual dysphoric disorder (PMDD). It is the combination of ethinyl estradiol and the diuretic drospirenone that make Yaz different than other birth control pills. But that combination has proven deadly to numerous women who have taken it, including 20-year-old Leah.

Read the rest of this entry »

Bayer Healthcare Corp. says it sufficiently warned women that there was a risk of life-threatening side effects associated with its oral contraceptives, Yaz and Yasmin. The drug company claims that all birth control pills carry warnings of possible side effects and that if taken properly, their drugs are safe.

Read the rest of this entry »

Yaz and Yasmin lawsuits filed against Bayer Healthcare in Pennsylvania state courts were consolidated into a mass tort last week by Philadelphia Court of Common Pleas judge Sandra Mazer Moss, who appointed 3 Pennsylvania attorneys to serve as liaison counsel for the plaintiffs.

Read the rest of this entry »